Concepedia

Diana Kelder

DK

Statistics

Publications

14

Citations

440

H-Index

12

Active since

1976

Affiliations

AstraZeneca (Sweden)(Current)

Södertälje Sjukhus

Diana Kelder is an author at AstraZeneca (Sweden) specializing in medicine, physiology, and neuropharmacology.

Top concepts

Publications per year

1976–2001

14

Publications

14

The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine1A Receptor Antagonist, NAD-299

L. E. B. Johansson, Daniel Sohn, Seth-Olof Thorberg et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 130 citations · Full text

Efflux of 5‐Hydroxytryptamine from Synaptosomes of Rat Cerebral Cortex

Svante B. Ross, Diana Kelder · Acta Physiologica Scandinavica · 1977 · 43 citations

Forebrain projections of the ventral tegmentum as studied by axonal transport of [3H]dopamine in the rat

Lena Haglund, Christer Köhler, Svante B. Ross et al. · Neuroscience Letters · 1979 · 35 citations

, , +14

Long lasting attenuation of 8-OH-DPAT induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist

Diana Kelder, Svante B. Ross · Naunyn-Schmiedeberg s Archives of Pharmacology · 1992 · 35 citations

, , +6

N-Methyl-D-aspartate receptor antagonists counteract the long lasting 5-HT1A receptor-induced attenuation of postsynaptic responses in the rat in vivo

Svante B. Ross, Lucy R�nyi, Diana Kelder · Naunyn-Schmiedeberg s Archives of Pharmacology · 1992 · 33 citations

, , +9

1–5 of 14